IV Busulfan (Bu) with fludarabine (Flu) or cyclophosphamide (Cy) - Comparing ablative conditioning regimens for allogeneic transplantation in AMLIMDS.

被引：0
|
作者：
de Lima, M
Couriel, D
Shahjahan, M
Alamo, J
Thall, PF
Russell, J
Anderlini, P
Giralt, S
Shpall, EJ
Jones, RB
Champlin, RE
Andersson, BS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
[2] Albert BMT Program, Calgary, AB, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.97.97
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
97
引用
收藏
页码：31A / 31A
页数：1
相关论文
共 50 条
  • [1] Long-term follow-up of IV busulfan (Bu) with fludarabine (Flu) vs IV bu with cyclophosphamide (Cy) as pre (Allogeneic) transplant conditioning therapy forAML/MDS.
    De Lima, Marcos
    Wang, X.
    Thall, P. F.
    Couriel, D.
    Jones, R. B.
    Shpall, E. J.
    Popat, U.
    Giralt, S.
    Korbling, M.
    Champlin, R.
    Andersson, B. S.
    BLOOD, 2006, 108 (11) : 100A - 100A
  • [2] Pretransplant conditioning with IV busulfan (Bu) and fludarabine (Flu) as alternative to Bu and cyclophosphamide (Cy) - A safe, myeloablative regimen with high antileukemic efficacy in AML/MDS
    de Lima, M
    Couriel, D
    Shahjahan, M
    Alamo, J
    Madden, T
    Thapar, N
    Russel, J
    Anderlini, P
    Giralt, S
    Shpall, E
    Jones, R
    Champlin, R
    Andersson, B
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 63 - 63
  • [3] COMPARISON OF IV BUSULFAN AND FLUDARABINE VS IV BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN IN MYELOABALTIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    de Villambrosia, S. Gonzalez
    Moreto, A.
    Nunez, J.
    Bermudez, A.
    Yanez, L.
    Insunza, A.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 142 - 142
  • [4] Myeloablative conditioning with fludarabine and iv-busulfan for allogeneic stem cell transplantation: a comparison with BU-CY2 in acute myeloid leukaemia
    Nacer, R. Ahmed
    Benakli, M.
    Talbi, A.
    Mehdid, F.
    Belhadj, R.
    Rahmoune, N.
    Ouali, D. Ait
    Baazizi, M.
    Hamladji, R. -M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S269 - S269
  • [5] Superior Outcomes with Fludarabine-Busulfan (Flu/Bu) Based Conditioning for Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis - a Comparative Analysis By CIBMTR
    Murthy, Guru Subramanian Guru
    Kim, Soyoung
    Estrada-Merly, Noel
    Sobecks, Ronald M.
    Oran, Betul
    Nakamura, Ryotaro
    Scott, Bart L.
    Saber, Wael
    BLOOD, 2021, 138
  • [6] Comparison of Bu-Cy-based standard myeloablative conditioning vs. fludarabine and busulfan (Flu-Bu)-based reduced-intensity conditioning
    Mohty, M.
    Labopin, M.
    Socie, G.
    Milpied, N.
    Attal, M.
    Blaise, D.
    Ringden, O.
    Brown, P.
    Lorentz, B.
    Brune, M.
    Hamladji, R. M.
    Duarte, R. F.
    Nagler, A.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S55 - S56
  • [7] Phase one study of intravenous (iv) busulfan (BU) and cyclophosphamide (CY) as pretransplantation conditioning therapy.
    Andersson, BS
    Madden, T
    Hu, W
    Chow, D
    Vaughn, WP
    Blume, K
    Williams, TE
    Champlin, RE
    BLOOD, 1995, 86 (10) : 863 - 863
  • [8] Intravenous(IV) Busulfan (BU) Pharmacokinetics Using Busulfan and Fludarabine (Flu) Conditioning in Institutions Where the Capability of Doing Pharmacokinetics Is Not Present
    Gul, Zartash
    Arora, Shaily
    Lawson, Amber
    Weiss, Heidi L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S98 - S98
  • [9] MYELOABLATIVE CONDITIONING WITH FLUDARABINE AND (IV) BUSULFAN (F-BU4) FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASIC SYNDROMES
    Talbi, A.
    Nacer, R. Ahmed
    Benakli, M.
    Mehdid, F.
    Belhadj, R.
    Rahmoune, N.
    Baazizi, M.
    Ouali, D. Ait
    Bouarab, H.
    Harieche, F.
    Hamladji, R. M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S186 - S187
  • [10] UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION USING HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY) CONDITIONING REGIMEN
    SAHEBI, F
    BOLWELL, B
    CRILLEY, P
    FRANE, M
    TERRITO, M
    GAJEWSKI, J
    COPELAN, E
    BLOOD, 1993, 82 (10) : A81 - A81
12345